Featured Bioprocessing Editorial
-
Using Digital Shadows To Reinforce Downstream Modeling
3/26/2025
This model class transfers real-time information in one direction, and it can help bridge the gap between digital model and fully functioning digital twin.
-
The Importance Of Primary And Secondary Drying And Their Impact On Lyophilization
3/25/2025
For parenteral formulations, biologics, and vaccines, the lyophilization process's primary and secondary drying stages require precise control of temperature, vacuum, and duration.
-
Counting The Steps To Decentralized Personalized Therapy Manufacturing
3/21/2025
AltruBio's CEO has a rough map of the steps to distributed cell therapy manufacturing. She discusses the path and some of the obstacles we'll need to clear first.
-
Upskilling Your Quality Team For The AI Revolution In Pharma 4.0
3/21/2025
While AI systems offer advanced capabilities for data analysis, process optimization, and quality assessments, your quality team must first be proficient in interacting with them.
-
3 Strategies For mAb Manufacturing: How Do You Choose?
3/19/2025
As cost and supply come under more scrutiny, there are primarily three scaling strategies for mAb manufacturing that can be leveraged, each with its own set of pros and cons.
-
A Practical Guide To Defining Priority Data In MES
3/17/2025
Manufacturing execution systems (MES) play a crucial role in pharma/biotech, but MES platforms face the challenge of identifying the critical data that should be prioritized for supporting effective operations.
-
How Is The Market Responding To Brisk HPAPI Demand?
3/17/2025
The rise of precision medicine like ADCs has created new markets for highly potent API. More suppliers are building out capacity to meet the demand.
-
Do Patient Needs Define Biologic Product Specifications?
3/14/2025
Enhanced product understanding acknowledges the technology advancements of the last 25 years and substantially more complex drug modalities.
-
Are CDMO Partnerships The Answer To Manufacturing Capacity Issues?
3/13/2025
The current manufacturing strain is exacerbated by factors such as the intensity of scaling up fill-finish and specialized manufacture of drug delivery devices. How can partnering with a CDMO help?
-
A Snapshot Of What Pfizer's Doing With Teleoperated Robots
3/12/2025
A robotic arm controlled with a virtual reality headset and input devices could aid in complex interventions where automation isn't practical.